Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Buprenorphine recalled?

Yes — there is an active recall. 5 ongoing FDA recalls mention Buprenorphine (31 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Buprenorphine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Buprenorphine recalls on record

none so far in 2026; 31 on record, newest first
Class II · Moderate risk

Buprenorphine 0.1/0.05 Mg/Ml Cream

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Terminated Sterility / contamination Beacon Hill Medical Pharmacy, P.C. D-1015-2013
Class II · Moderate risk

Buprenorphine HCL Sl

Labeling: Label Mixup: BUPRENORPHINE HCL SL, Tablet, 2 mg may be potentially mislabeled as one of the following drugs: DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: AD37072_4, EXP: 5/13/2014; MAGNESIUM CHLORIDE DR, Tablet, 64 mg, NDC 00904791152, Pedigree: AD54510_1, EXP: 2/28/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-796-2014
Class II · Moderate risk

Buprenorphine Injection

Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

Terminated Sterility / contamination FVS Holdings, Inc. dba. Green Valley Drugs D-353-2013